Inventor
Aoli Wang
Inventor
Anhui, CN
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations32%
C07DHeterocyclic compounds32%
A61KPreparations for medical, dental or toiletry purposes26%
Y02PClimate change mitigation technologies in the production or processing of goods11%
PatentTitleYear
10,793,543Selective C-KIT kinase inhibitor202010,781,214Kinase inhibitor against wild-type and mutant EGFR202010,669,238Irreversible bruton's tyrosine kinase inhibitor202010,350,210EGFR and ALK dual inhibitor201910,266,535Inhibitor of FLT3 kinase and use thereof20199,814,709'Bruton\'s tyrosine kinase inhibitor'2017Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2017–2020Patents assigned to HEFEI INST PHYSICAL SCI CAS (3)· patent assignee history
2017Patents assigned to ANHUI NEW STAR PHARMACEUTICAL DEV CO LTD (1)· patent assignee history
2017Based in Hefei, CN· patent location history
2019–2020Patents assigned to PRECEDO PHARMACEUTICALS CO LTD (3)· patent assignee history
2019Patents assigned to HEFEI COSOURCE PHARMACEUTICAL CO LTD (1)· patent assignee history
2019–2020Based in Anhui, CN· patent location history
2020Patents assigned to HEFEI GRACEVO BIO MEDICINE CO LTD (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| HEFEI INST PHYSICAL SCI CAS | 3 | 2017–2020 |
| PRECEDO PHARMACEUTICALS CO LTD | 3 | 2019–2020 |
| ANHUI NEW STAR PHARMACEUTICAL DEV CO LTD | 1 | 2017 |
| HEFEI COSOURCE PHARMACEUTICAL CO LTD | 1 | 2019 |
| HEFEI GRACEVO BIO MEDICINE CO LTD | 1 | 2020 |
Locations
| Location | Patents | Span |
|---|---|---|
| Anhui, CN | 5 | 2019–2020 |
| Hefei, CN | 1 | 2017 |